Factors influencing the clinical ineffectiveness of antibiotics in non-responders

Sivakumar Velusamy; Saravanan Thangavelu; Monica Sherin Thomas; Monisha Harinathan

doi:10.18203/2319-2003.ijbcp20253376

Authors

Sivakumar Velusamy Department of Pharmacy Practice, PSG College of Pharmacy, Coimbatore, India
Saravanan Thangavelu Department of General Medicine, PSG Super Speciality Hospitals, Coimbatore, India
Monica Sherin Thomas Department of Pharmacy Practice, PSG College of Pharmacy, Coimbatore, India
Monisha Harinathan Department of Pharmacy Practice, PSG College of Pharmacy, Coimbatore, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20253376

Keywords:

Ineffectiveness, Antibiotics, Non-response, Factors, Culture sensitivity

Abstract

Background: Antibiotic ineffectiveness and clinical non-responsiveness remain significant challenges in healthcare. Non-responders-patients who fail to improve despite appropriate antibiotic therapy-pose a substantial clinical burden. Identifying factors influencing such outcomes is essential for improving treatment success. To investigate patient, hospital-related factors contributing to antibiotic ineffectiveness despite culture sensitivity.

Method: A six-month ambispective observational study was conducted at PSG Hospitals, Coimbatore, India. A total of 480 inpatients were included into the study. Highly prescribed antibiotics-Cefoperazone+Sulbactam, Meropenem, Piperacillin Tazobactam, and Ceftriaxone-were analyzed. Factors such as age, gender, type of bacteria, prior antibiotic exposure, prior hospitalization, invasive procedures, and length of hospital stay were examined. Statistical analysis was performed using SPSS, with p values < 0.05 considered significant.

Results: Among 480 patients equally divided across four antibiotic groups, age was significant in the Meropenem group (p=0.044) in contrast to the rest of the groups. Prior antibiotic exposure (OR range: 1.091–1.889; p<0.05) and longer hospital stay (OR range: 1.271–1.710; p<0.001) were significantly associated with non-response across all the four antibiotic groups. Klebsiella pneumoniae was significantly linked to non-response across all groups (OR range: 1.025–1.801; all p<0.01). Invasive procedures were significant for Cefoperazone–Sulbactam (OR=2.148, p=0.030) and Piperacillin–Tazobactam (OR=1.643, p=0.012).

Conclusion: Prior antibiotic exposure, prolonged hospital stays, and the presence of Klebsiella pneumoniae were significantly associated with antibiotic non-responsiveness. This suggests a multifaceted approach addressing patient, microbial, and institutional factors might lessen disruptions to optimal clinical effectiveness.

Metrics

Metrics Loading ...

References

Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther. 2015;40(4):277–83.

Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000;31(4):131–40. DOI: https://doi.org/10.1086/314079

Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C; ANZICS CORE Management Committee. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care. 2009;13(3):91. DOI: https://doi.org/10.1186/cc7921

Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001;7(2):277–81. DOI: https://doi.org/10.3201/eid0702.010226

Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–22. DOI: https://doi.org/10.1126/science.284.5418.1318

Høiby N. A short history of microbial biofilms and biofilm infections. APMIS. 2017;125(4):272–5. DOI: https://doi.org/10.1111/apm.12686

Pea F, Viale P, Pavan F, Furlanut M. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin Pharmacokinet. 2007;46(12):997–1038. DOI: https://doi.org/10.2165/00003088-200746120-00003

Huttner A, Harbarth S, Carlet J, Cosgrove S, Goossens H, Holmes A, et al. Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrob Resist Infect Control. 2013;2:31. DOI: https://doi.org/10.1186/2047-2994-2-31

Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284–90. DOI: https://doi.org/10.1007/s11606-010-1253-9

Ali M, Garba KA, Abdallah MS. Antibiotic susceptibility profile of bacteria responsible for urinary tract infection (UTI). South Asian J Biol Res. 2018;1(1):12–27.

Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198–208. DOI: https://doi.org/10.1056/NEJMoa1306801

Wongsurakiat P, Chitwarakorn N. Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection. BMC Pulm Med. 2019;19:94. DOI: https://doi.org/10.1186/s12890-019-0944-1

Chaturvedi P, Lamba M, Sharma D, Mamoria VP. Bloodstream infections and antibiotic sensitivity pattern in intensive care unit. Trop Doct. 2020;50(4):290–4.

Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589–603. DOI: https://doi.org/10.1128/CMR.11.4.589

Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014;14(6):498–509. DOI: https://doi.org/10.1016/S1473-3099(14)70036-2